-
Know Labs, Inc. has entered a transformative agreement with fintech investor Greg Kidd’s Goldeneye 1995 LLC, involving a substantial 1,000 Bitcoin transfer that is set to redefine its corporate strategy.
-
This strategic deal not only includes Bitcoin but also $12 to $15 million in cash, aimed at debt repayment, preferred stock repurchase, and bolstering working capital, signaling a robust financial restructuring.
-
According to COINOTAG, Greg Kidd emphasized, “I’m thrilled to deploy a Bitcoin treasury strategy with the support of a forward-looking organization like Know Labs at a time when market and regulatory conditions are particularly favorable.”
Know Labs’ major deal with 1,000 BTC and $12-$15M cash marks a pivotal shift under ex-Ripple exec Greg Kidd, spotlighting innovative Bitcoin treasury strategies.
Know Labs’ Strategic Acquisition of 1,000 Bitcoin Highlights New Financial Direction
In a landmark move, Know Labs, Inc., a health-tech company specializing in non-invasive monitoring devices, has agreed to sell a controlling interest to Goldeneye 1995 LLC, an affiliate of Greg Kidd, a seasoned fintech investor and former Ripple Chief Risk Officer. The transaction, expected to close in Q3 2025 pending shareholder approval, includes 1,000 Bitcoin and a cash infusion between $12 million and $15 million. This combination of digital and fiat assets is designed to strengthen Know Labs’ balance sheet by repaying existing debts, repurchasing preferred stock, and providing essential working capital. The shares involved in the deal are priced at $0.335 each, below the current trading price, reflecting a strategic valuation approach tied to the total asset value.
Greg Kidd’s Leadership and Bitcoin Treasury Strategy to Drive Public Market Innovation
Greg Kidd’s appointment as CEO and Chairman marks a significant leadership transition for Know Labs. Kidd, renowned for his early investments in Twitter, Square, and Coinbase, brings a wealth of fintech expertise and a pioneering Bitcoin yield strategy. His vision is to integrate this strategy into the public markets via Know Labs, positioning Bitcoin as the company’s primary asset. Kidd’s statement underscores the timeliness of this move, citing favorable market and regulatory conditions. The Bitcoin holdings are projected to constitute 82% of Know Labs’ anticipated $128 million market capitalization, based on a Bitcoin price of $105,000 per coin. This strategic asset allocation will be monitored through the multiple of net asset value (mNAV), with an entry multiple estimated at 1.22x, providing investors with a transparent metric to assess value.
Corporate Governance and Shareholder Support Cement Deal’s Prospects
The transaction has received unanimous approval from Know Labs’ board, with approximately 37% of shareholders already backing the deal. This strong governance support is critical for the anticipated closing later this year. Key personnel changes include Ron Erickson, the company’s founder, transitioning to Vice Chairman and President of a new research division with a salary adjustment, while Peter Conley will step down post-closing. Legal and financial advisory roles are being fulfilled by Cohen & Company Capital Markets, Lowenstein Sandler LLP, and Sichenzia Ross Ference Carmel LLP, ensuring comprehensive oversight and regulatory compliance throughout the process.
Market Implications and Future Outlook for Know Labs and Bitcoin Integration
This deal represents a pioneering example of a health-tech company embracing Bitcoin as a core treasury asset, potentially setting a precedent for similar enterprises. By leveraging Bitcoin’s value and Kidd’s fintech acumen, Know Labs aims to unlock new avenues for capital growth and investor engagement. The company’s approach to tracking market valuation through mNAV multiples offers a novel framework for assessing the interplay between cryptocurrency assets and traditional equity. Investors and market watchers should closely monitor Know Labs’ performance post-transaction, as it may influence broader trends in corporate Bitcoin adoption and fintech innovation.
Conclusion
Know Labs’ agreement with Greg Kidd’s Goldeneye 1995 LLC, featuring a substantial Bitcoin allocation and cash infusion, signals a strategic pivot towards integrating cryptocurrency into corporate finance. With strong leadership, shareholder backing, and a clear focus on leveraging Bitcoin’s market potential, Know Labs is poised to navigate a transformative phase that could reshape its financial landscape and inspire similar moves within the industry. This development highlights the growing intersection of fintech expertise and blockchain assets in driving corporate innovation.
